Abstract: Antimicrobials are commonly prescribed for the treatment of equine asthma, despite limited evidence supporting their use. Tracheal wash (TW) bacterial culture results are known to influence antimicrobial prescription decisions. Objective: To determine whether a positive TW bacterial culture in horses with asthma is associated with bronchial infection or colonisation, increased bronchial remodelling and airway inflammation by evaluating the presence of bacteria and airway remodelling in endobronchial biopsies, as well as bronchoalveolar lavage fluid (BALF) cytology and tracheal mucus scores. Methods: Retrospective blinded case-control study. Methods: Tracheal wash aerobic bacterial culture, endobronchial biopsies, BALF cytology and tracheal mucus scores from horses with severe equine asthma (SEA) (n = 13), mild-to-moderate equine asthma (MEA) (n = 9) and control horses (n = 9) were evaluated. Results: Tracheal wash cultures were positive in 8/13 horses with SEA, 6/9 horses with MEA and 8/9 control horses. No bacteria were identified on Gram stains in any endobronchial biopsy samples. Semiquantitative histologic scores from endobronchial biopsies did not differ significantly between asthmatic horses with positive versus negative TW cultures (p = 0.4). Neutrophil percentages in BALF were not significantly different between asthmatic horses with a positive and negative TW culture (p = 0.5). Tracheal mucus scores did not differ between asthmatic horses with positive versus negative TW cultures (p = 0.7). Conclusions: Small sample size, absence of endobronchial biopsies with bacterial presence. Conclusions: A positive bacterial TW culture in horses with asthma is not associated with bronchial infection, bacterial colonisation, increased bronchial remodelling or increased airway inflammation. Therefore, a positive TW culture in these cases does not confirm the presence of a secondary bacterial infection. Tracheal wash culture results alone should not be considered a primary determinant when making treatment decisions for equine asthma.
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
Overview
This study investigated whether a positive bacterial culture from a tracheal wash (TW) in horses with asthma indicates true bronchial infection, airway remodeling, or inflammation.
Findings showed that positive TW cultures do not correlate with bronchial infection or worsening asthma features, suggesting antimicrobial treatment based solely on TW culture results may be unwarranted.
Background and Objective
Antimicrobials are frequently prescribed for equine asthma despite limited evidence supporting their efficacy in this context.
Veterinarians often rely on bacterial culture results from tracheal wash samples to decide on antimicrobial use.
The study aimed to determine if positive bacterial cultures from TW samples in asthmatic horses are linked to:
Actual bronchial infection or bacterial colonization
Increased bronchial remodeling (structural changes in the airway)
Elevated airway inflammation
Evaluations included: analyzing endobronchial biopsy samples for bacteria and remodeling, bronchoalveolar lavage fluid (BALF) cytology for inflammation, and scoring tracheal mucus.
Methods
The study was a retrospective, blinded case-control design.
Sample groups included:
13 horses with severe equine asthma (SEA)
9 horses with mild-to-moderate equine asthma (MEA)
9 control horses without asthma
For all horses, researchers collected and analyzed:
Tracheal wash aerobic bacterial cultures
Endobronchial biopsies for histological analysis and bacterial presence using Gram stains
Bronchoalveolar lavage fluid (BALF) cytology to measure neutrophil percentages as inflammation markers
Tracheal mucus scoring to assess mucus accumulation
Results
Positive TW bacterial cultures were found in:
8 out of 13 SEA horses
6 out of 9 MEA horses
8 out of 9 control horses
No bacteria were detected in any endobronchial biopsy specimens when using Gram stains.
Histologic scores assessing bronchial remodeling did not significantly differ between asthmatic horses with positive versus negative TW cultures (p=0.4).
Neutrophil percentages in BALF, indicating airway inflammation, also showed no significant difference between horses with positive and negative TW cultures (p=0.5).
Tracheal mucus scores were similar regardless of TW culture results (p=0.7).
Conclusions
Positive bacterial cultures from tracheal washes in horses with asthma do not equate to clear evidence of bronchial infection or colonization.
There is no associated increase in bronchial remodeling or airway inflammation linked to positive TW cultures.
The study emphasizes that TW culture results alone are insufficient to confirm secondary bacterial infections in asthmatic horses.
Consequently, veterinarians should avoid basing antimicrobial treatment decisions solely on TW culture results in equine asthma cases.
The study acknowledged limitations such as a small sample size and the absence of bacterial detection in biopsy samples, which may influence generalizability.
Significance and Implications
This research challenges the common practice of prescribing antimicrobials for equine asthma based purely on positive TW bacterial culture findings.
It promotes more judicious use of antimicrobials, potentially reducing unnecessary antibiotic exposure and the risk of antimicrobial resistance.
Future studies with larger sample sizes and advanced bacterial detection techniques could help validate these findings and influence clinical guidelines.
Cite This Article
APA
Leduc L, St-Jean G, Lavoie JP.
(2026).
Tracheal wash culture is not associated with bronchial infection, remodelling or inflammation in horses with asthma.
Equine Vet J.
https://doi.org/10.1002/evj.70157
Normansell R, Sayer B, Waterson S, Dennett EJ, Del Forno M, Dunleavy A. Antibiotics for exacerbations of asthma.. Cochrane Database Syst Rev 2018;6:CD002741.
Murray CS, Lucas SJ, Blakey J, Kaplan A, Papi A, Paton J. A real‐life comparative effectiveness study into the addition of antibiotics to the management of asthma exacerbations in primary care.. Eur Respir J 2021;58:2003599.
Reddel HK, Bacharier LB, Bateman ED, Brightling CE, Brusselle GG, Buhl R. Global initiative for asthma strategy 2021: executive summary and rationale for key changes.. Am J Respir Crit Care Med 2022;205:17–35.
Redel AL, Feleszko W, Arcolaci A, Cefaloni F, Atanaskovic‐Markovic M, Braunstahl GJ. A survey study on antibiotic prescription practices for acute asthma exacerbations: an European academy of allergy and clinical immunology task force report.. Clin Transl Allergy 2024;14:e12345.
Dickson RP, Erb‐Downward JR, Freeman CM, McCloskey L, Beck JM, Huffnagle GB. Spatial variation in the healthy human lung microbiome and the adapted Island model of lung biogeography.. Ann Am Thorac Soc 2015;12:821–830.
Dickson RP, Erb‐Downward JR, Huffnagle GB. Homeostasis and its disruption in the lung microbiome.. Am J Physiol Lung Cell Mol Physiol 2015;309:L1047–L1055.
Charlson ES, Bittinger K, Haas AR, Fitzgerald AS, Frank I, Yadav A. Topographical continuity of bacterial populations in the healthy human respiratory tract.. Am J Respir Crit Care Med 2011;184:957–963.
Ver Heul A, Planer J, Kau AL. The human microbiota and asthma.. Clin Rev Allergy Immunol 2019;57:350–363.
Wu BG, Sulaiman I, Tsay J‐CJ, Tsay J‐CJ, Perez L, Franca B. Episodic aspiration with oral commensals induces a MyD88‐dependent, pulmonary T‐helper cell type 17 response that mitigates susceptibility to Streptococcus pneumoniae.. Am J Respir Crit Care Med 2021;203:1099–1111.
Gibson PG, Yang IA, Upham JW, Reynolds PN, Hodge S, James AL. Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double‐blind, placebo‐controlled trial.. Lancet 2017;390:659–668.